Cirillo Federica, Resmini Giulia, Angelino Elia, Ferrara Michele, Tarantino Adriana, Piccoli Marco, Rota Paola, Ghiroldi Andrea, Monasky Michelle M, Ciconte Giuseppe, Pappone Carlo, Graziani Andrea, Anastasia Luigi
Laboratory of Stem Cells for Tissue Engineering, IRCCS Policlinico San Donato, San Donato Milanese, Italy.
Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Front Cell Dev Biol. 2020 Nov 11;8:593508. doi: 10.3389/fcell.2020.593508. eCollection 2020.
Herein we unveil that Hypoxia-inducible factor-1α (HIF-1α) directly regulates expression during myogenesis. In fact, chromatin immunoprecipitation (ChiP) and site-directed mutagenesis experiments revealed two distinct hypoxia response elements (HREs) that are specific HIF-1α binding sites on the promoter. Remarkably, a pharmacological activation of HIF-1α induced expression and enhanced muscle differentiation. On the other hand, silencing of using CRISPR/Cas9 genome editing blocked the effects of HIF-1α activation on myogenesis. Finally, treatment with prolyl hydroxylases (PHDs) inhibitors improved muscle regeneration and in a cardiotoxin (CTX)-induced muscle injury mouse model, paving the way for further studies to test its efficacy on acute and chronic muscular pathologies.
在此我们揭示缺氧诱导因子-1α(HIF-1α)在肌生成过程中直接调节基因表达。事实上,染色质免疫沉淀(ChiP)和定点诱变实验揭示了两个不同的缺氧反应元件(HREs),它们是基因启动子上特定的HIF-1α结合位点。值得注意的是,HIF-1α的药理学激活诱导了基因表达并增强了肌肉分化。另一方面,使用CRISPR/Cas9基因组编辑沉默基因阻断了HIF-1α激活对肌生成的影响。最后,在心脏毒素(CTX)诱导的肌肉损伤小鼠模型中,用脯氨酰羟化酶(PHDs)抑制剂治疗改善了肌肉再生和功能,为进一步研究其对急性和慢性肌肉疾病的疗效铺平了道路。